Hallgeir Rui

Citée par

	Toutes	Depuis 2016
Citations	8822	2513
indice h	54	28
indice i10	133	71

540

270

135

405

19921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202137 38 90 150 174 162 211 190 204 148 166 237 202 222 214 274 321 276 397 427 475 521 474 516 514 426 419 456 520 176

Accès public

Tout afficher

54 articles

2 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Richard PestellDirector of Kimmel Cancer Center and Executive VP, Thomas Jefferson UniversityAdresse e-mail validée de jefferson.edu
T HyslopProfessor, Duke UniversityAdresse e-mail validée de duke.edu
Michael P. Lisanti, MD-PhD, FRSA, FR...Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)Adresse e-mail validée de salford.ac.uk
Kay-Uwe WagnerProfessor, Karmanos Cancer Institute, Wayne State UniversityAdresse e-mail validée de karmanos.org
Inna ChervonevaProfessor of Biostatistics, Thomas Jefferson UniversityAdresse e-mail validée de jefferson.edu
Federica Sotgia, PhDProfessor & Chair, University of Salford (Greater Manchester), UKAdresse e-mail validée de salford.ac.uk
Lawrence Andrew ShirleyAssistant Professor of Surgery, The Ohio State UniversityAdresse e-mail validée de osu.edu
David RimmYale UniversityAdresse e-mail validée de yale.edu
Lothar HennighausenScientist and RandonneurAdresse e-mail validée de mail.nih.gov
Xuanmao JiaoPh.D., Associate Professor, Baruch S. Blumberg InstituteAdresse e-mail validée de bblumberg.org
Lukas BubendorfProfessor, Institute of Pathology, University Hospital BaselAdresse e-mail validée de usb.ch
Isabelle MercierUniversity of the Sciences in PhiladelphiaAdresse e-mail validée de usciences.edu
Gloria Bonuccelli, PhDUniversity of SalfordAdresse e-mail validée de salford.ac.uk
Peter McCueDirector of Pathology, Jefferson UniversityAdresse e-mail validée de jefferson.edu
Magliocco AnthonyH Lee Moffitt Cancer CenterAdresse e-mail validée de moffitt.org
Hai HuChief Scientific Officer, Chan Soon-Shiong Institute of Molecular Medicine at WindberAdresse e-mail validée de wriwindber.org
Chenguang WangLIPOGEN LLC.Adresse e-mail validée de lipogenes.com
Jan Oxholm GordeladzeProfessor, PhD, Institute of Basic Medical Science, Department of Biochemistry, University of Oslo, NorwayAdresse e-mail validée de medisin.uio.no
Leonard GomellaProfessor of Urology, Thomas Jefferson UniversityAdresse e-mail validée de jefferson.edu
Chelain R. Goodman, MD, PhDNorthwestern University Feinberg School of MedicineAdresse e-mail validée de northwestern.edu

Hallgeir Rui

Professor of Pathology, Medical College of Wisconsin

Adresse e-mail validée de mcw.edu - Page d'accueil

Breast Cancer


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Activation of receptor-associated tyrosine kinase JAK2 by prolactin. H Rui, RA Kirken, WL Farrar Journal of Biological Chemistry 269 (7), 5364-5368, 1994	385	1994
Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer D Li, Y Zhao, C Liu, X Chen, Y Qi, Y Jiang, C Zou, X Zhang, S Liu, X Wang, ... Clinical cancer research 17 (7), 1722-1730, 2011	308	2011
Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation PM Grimley, F Dong, H Rui Cytokine & growth factor reviews 10 (2), 131-157, 1999	253	1999
Signal transducer and activator of transcription-5 activation and breast cancer prognosis MT Nevalainen, J Xie, J Torhorst, L Bubendorf, P Haas, J Kononen, ... Journal of Clinical Oncology 22 (11), 2053-2060, 2004	244	2004
Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells AS Sultan, J Xie, MJ LeBaron, EL Ealley, MT Nevalainen, H Rui Oncogene 24 (5), 746-760, 2005	208	2005
Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580 L DaSilva, H Rui, RA Erwin, OMZ Howard, RA Kirken, MG Malabarba, ... Molecular and cellular endocrinology 117 (2), 131-140, 1996	190	1996
Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells H Yamashita, J Xu, RA Erwin, WL Farrar, RA Kirken, H Rui Journal of Biological Chemistry 273 (46), 30218-30224, 1998	171	1998
Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors L DaSilva, OM Howard, H Rui, RA Kirken, WL Farrar Journal of Biological Chemistry 269 (28), 18267-18270, 1994	171	1994
Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice KU Wagner, A Krempler, AA Triplett, Y Qi, NM George, J Zhu, H Rui Molecular and cellular biology 24 (12), 5510-5520, 2004	164	2004
Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells TJ Ahonen, J Xie, MJ LeBaron, J Zhu, M Nurmi, K Alanen, H Rui, ... Journal of Biological Chemistry 278 (29), 27287-27292, 2003	161	2003
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response A Ertel, JL Dean, H Rui, C Liu, A Witkiewicz, KE Knudsen, ES Knudsen Cell cycle 9 (20), 4153-4163, 2010	154	2010
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization H Rui, JJ Lebrun, RA Kirken, PA Kelly, WL Farrar Endocrinology 135 (4), 1299-1306, 1994	153	1994
Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. H Rui, JY Djeu, GA Evans, PA Kelly, WL Farrar Journal of Biological Chemistry 267 (33), 24076-24081, 1992	152	1992
Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression KU Wagner, H Rui Journal of mammary gland biology and neoplasia 13 (1), 93-103, 2008	150	2008
Effects of growth hormone and prolactin immune development and function WJ Murphy, H Rui, DL Longo Life sciences 57 (1), 1-14, 1995	139	1995
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer AK Witkiewicz, A Dasgupta, K Nguyen, C Liu, AJ Kovatich, GF Schwartz, ... Cancer biology & therapy 8 (11), 1071-1079, 2009	138	2009
Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless RA Erwin, RA Kirken, MG Malabarba, WL Farrar, H Rui Endocrinology 136 (8), 3512-3518, 1995	118	1995
Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. JY Djeu, JH Liu, S Wei, H Rui, CA Pearson, WJ Leonard, DK Blanchard The Journal of Immunology 150 (3), 960-970, 1993	117	1993
Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment KV Katlinski, J Gui, YV Katlinskaya, A Ortiz, R Chakraborty, ... Cancer cell 31 (2), 194-207, 2017	114	2017
Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture TJ Ahonen, PL Härkönen, J Laine, H Rui, PM Martikainen, ... Endocrinology 140 (11), 5412-5421, 1999	110	1999

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Importer un PDF

Suivre les mises à jour de cet auteur

Citée par

Coauteurs